Compare Sana Biotechnology Inc (SANA) vs Yum China Holdings Inc (YUMC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sana Biotechnology Inc vs Yum China Holdings Inc — how do they compare? Sana Biotechnology Inc trades at $2.79 (market cap $836.71M), while Yum China Holdings Inc trades at $42.92 (market cap $14.11B). The key difference: Yum China Holdings Inc is far larger — about 16.9× Sana Biotechnology Inc's market cap, and Yum China Holdings Inc pays a 2.78% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Sana Biotechnology Inc for 23 Days and Yum China Holdings Inc for 77 Days on average.
| SANA | YUMC | |
|---|---|---|
Market Cap | $836.71M | $14.11B |
Volume | 4,507,444 | 2,350,650 |
Sector | Health | Consumer Cyclical |
52-Week High | $5.92 | $57.95 |
52-Week Low | $2.68 | $39.98 |
Typical Hold Time | 23 Days | 77 Days |
Enterprise Value | $749.96M | $15.02B |
Dividend Yield | — | 2.78% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SANA Biotechnology trades at $2.79, up 2.57% today, but faces significant fundamental challenges with no revenue, negative EBITDA of -$192.96M, and deeply negative ROE of -152.87%. Technical indicators show bearish momentum with moving averages signaling sell pressure, though oscillators remain neutral. The company continues to burn cash with -$55.33M net cash flow in 2025, relying on financing activities to fund operations while advancing its cell therapy pipeline through multiple investor presentations.
Despite 82% analyst buy ratings and a $9.50 consensus price target, SANA represents a high-risk biotech investment with substantial execution risk. The absence of revenue, persistent losses, and cash burn require careful monitoring of clinical milestones. Near-term catalysts depend on pipeline progress, but shareholders face dilution risk from continued financing needs amid challenging technical conditions.
YUMC trades at $41.78, up 2.78% today, but technical indicators signal a bearish trend with strong sell signals from moving averages. Fundamentally, the company shows steady revenue growth, reaching $11.80B in 2025, with consistent earnings beats in recent quarters. Recent developments include the acquisition of Pizza Hut brand ownership in mainland China and expansion of Pizza Hut Burger Bars to 300 locations.
The outlook is mixed: strong analyst consensus (73.68% buy ratings) and a projected 25.63% upside suggest value, but bearish technicals and competitive pressures pose risks. Investors should weigh solid fundamentals against near-term price volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →About Yum China Holdings Inc
With almost 10,600 units and USD 9.5 billion in systemwide sales in 2020, Yum China is the largest restaurant chain in China. It generates revenue through its own restaurants and franchise fees. Key concepts include KFC (7,166 units) and Pizza Hut (2,355), but the company's portfolio also includes other brands such as Little Sheep, East Dawning, Taco Bell, Huang Ji Huang, COFFii & Joy, and Lavazza (collectively representing about 985 units). Yum China is a trademark licensee of Yum Brands, paying 3% of total systemwide sales to the company it separated from in October 2016.
Read more on YUMC →
